{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:10:26Z","timestamp":1762542626021,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.rvsc.2017.01.003","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T06:16:34Z","timestamp":1484201794000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers"],"prefix":"10.1016","volume":"112","author":[{"given":"Hong Ki","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"DeVito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Tramuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Nebbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaspars","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2017.01.003_bb0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2885.2005.00669.x","article-title":"Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats","volume":"28","author":"Albarellos","year":"2005","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0010","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2460\/ajvr.2001.62.1979","article-title":"Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration","volume":"62","author":"Aliabadi","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1090-0233(02)00258-7","article-title":"Pharmacokinetics and Pk\/Pd modelling of danofloxacin in camel serum and tissue cage fluids","volume":"165","author":"Aliabadi","year":"2003","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/AAC.47.2.626-635.2003","article-title":"Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids","volume":"47","author":"Aliabadi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/510079","article-title":"Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore","volume":"44","author":"Ambrose","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1996.tb00001.x","article-title":"Fluoroquinolones in animal health","volume":"19","author":"Brown","year":"1996","journal-title":"J. Vet. Pharmacol. Ther."},{"year":"2009","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Eighth Edition (M07-A8)","author":"Clinical and Laboratory Standards Institute (CLSI)","key":"10.1016\/j.rvsc.2017.01.003_bb0040"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0045","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/BF02389870","article-title":"Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens","volume":"12","author":"Craig","year":"1993","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/Pharmacodynamic parameters: rationale for antimicrobial dosing of mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/47.2.129","article-title":"Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy","volume":"47","author":"Dagan","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4142\/jvs.2007.8.4.357","article-title":"Disposition kinetics and dosage regimen of levofloxacin on concomitant administration with paracetamol in crossbred calves","volume":"8","author":"Dumka","year":"2007","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4142\/jvs.2006.7.4.333","article-title":"Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves","volume":"7","author":"Dumka","year":"2006","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0070","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11259-007-0090-8","article-title":"Disposition kinetics, urinary excretion and dosage regimen of levofloxacin formulation following single intravenous administration in crossbred calves","volume":"31","author":"Dumka","year":"2007","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0075","first-page":"2598","article-title":"The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010","volume":"10","author":"European Food Safety Authority","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-199732020-00002","article-title":"The clinical pharmacokinetics of levofloxacin","volume":"32","author":"Fish","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/AAC.37.5.1073","article-title":"Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients","volume":"37","author":"Forrest","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.jepm.2013.05.009","article-title":"Blood concentrations of enrofloxacin and the metabolite ciprofloxacin in yellow-bellied slider turtles (Trachemys scripta scripta) after a single intracoelomic injection of enrofloxacin","volume":"22","author":"Giorgi","year":"2013","journal-title":"J. Exot. Pet. Med."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2885.2008.01023.x","article-title":"Pharmacokinetics of levofloxacin in male camels (Camelus dromedarius)","volume":"32","author":"Goudah","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2885.2008.01001.x","article-title":"Pharmacokinetics, urinary excretion and milk penetration of levofloxacin in lactating goats","volume":"32","author":"Goudah","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1179\/joc.2005.17.5.484","article-title":"Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric gram-negative urinary tract infection pathogens","volume":"17","author":"Hansen","year":"2005","journal-title":"J. Chemotherapy."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0110","first-page":"139","article-title":"Pharmacokinetics and PK\/PD modelling of enrofloxacin in Meleagris gallopavo and Gallus domesticus","volume":"7","author":"Haritova","year":"2004","journal-title":"BJVM"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-7012(00)00241-4","article-title":"How to optimize the drop plate method for enumerating bacteria","volume":"44","author":"Herigstad","year":"2001","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-199528020-00005","article-title":"The importance of pharmacokinetic\/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents","volume":"28","author":"Hyatt","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0125","article-title":"Implications of fluoroquinolone contamination for the aquatic environment -a review","author":"Janecko","year":"2016","journal-title":"Environ. Contam. Toxicol."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s11259-009-9237-0","article-title":"Pharmacokinetic studies of levofloxacin after oral administration in healthy and febrile cow calves","volume":"33","author":"Kumar","year":"2009","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0135","first-page":"1006","article-title":"Pharmacokinetics of levofloxacin following intravenous and intramuscular administration in cattle calves","volume":"7","author":"Kumar","year":"2012","journal-title":"AJAVA"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tvjl.2015.04.016","article-title":"The use of antimicrobial agents in broiler chickens","volume":"205","author":"Landoni","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003495-199856030-00013","article-title":"Levofloxacin: its use in infections of the respiratory tract, skin, soft tissues and urinary tract","volume":"56","author":"Langtry","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0924-8579(02)00025-0","article-title":"Rational dosing of antimicrobial drugs: animals versus humans int","volume":"19","author":"Lees","year":"2002","journal-title":"J. Antimicrob. Agents"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2885.2004.00603.x","article-title":"Pharmacokinetic\/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine","volume":"27","author":"McKellar","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02491502","article-title":"Mechanisms of quinolone resistance","volume":"3","author":"Nakamura","year":"1997","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0165","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/j.1875-9114.1998.tb03925.x","article-title":"Levofloxacin a second generation fluoroquinolone","volume":"18","author":"North","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","article-title":"Pharmacokinetic-pharmacodynamic (PK-PD) modelling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs","volume":"171","author":"Papich","year":"2014","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0175","first-page":"85","article-title":"Pharmacokinetics of levofloxacin following intravenous and subcutaneous administration in sheep","volume":"7","author":"Patel","year":"2012","journal-title":"AJAVA"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0180","first-page":"121","article-title":"Pharmacokinetics, dosage regimen and in vitro plasma protein binding of intramuscular levofloxacin in buffalo calves","volume":"9","author":"Ram","year":"2008","journal-title":"Iranian J Vet. Res."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/45.3.321","article-title":"A retrospective analysis of pharmacokinetic\/pharmacodynamic indices as indicators of the clinical efficacy of ciprofloxacin","volume":"45","author":"Sanchez-Recio","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0190","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/314059","article-title":"Clinical pharmacology of the fluoroquinolones: studies in human dynamic\/kinetic models","volume":"31","author":"Schentag","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/AAC.42.3.521","article-title":"Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy","volume":"42","author":"Thomas","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0200","series-title":"World Buiatrics Congress 2006, Nice, France","article-title":"How antibiotic dosage regimens based on PK-PD concepts may be an important contribution to the resistance problem","author":"Toutain","year":"2006"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0205","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2885.2004.00613.x","article-title":"Integration and modeling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0034-5288(02)00039-5","article-title":"The pharmacokinetic- pharmacodynamic approach to a rational dosage regimen for antibiotics","volume":"73","author":"Toutain","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0215","first-page":"118","article-title":"Disposition of levofloxacin following oral administration in broiler chickens","volume":"64","author":"Varia","year":"2009","journal-title":"Isr. J. Vet. Med."},{"key":"10.1016\/j.rvsc.2017.01.003_bb0220","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jps.2600700208","article-title":"Ultrafiltration in serum protein binding determinations","volume":"70","author":"Whitlam","year":"1981","journal-title":"J. Pharm. Sci."},{"year":"2012","series-title":"Critically Important Antimicrobials for Human Medicine","author":"WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR)","key":"10.1016\/j.rvsc.2017.01.003_bb0225"},{"key":"10.1016\/j.rvsc.2017.01.003_bb0230","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/CMR.2.4.378","article-title":"Fluoroquinolones antimicrobial agents","volume":"2","author":"Wolfson","year":"1989","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528816304684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528816304684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:05:38Z","timestamp":1758513938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528816304684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":45,"alternative-id":["S0034528816304684"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.01.003","relation":{},"ISSN":["0034-5288"],"issn-type":[{"type":"print","value":"0034-5288"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}